Hubbry Logo
GenBankGenBankMain
Open search
GenBank
Community hub
GenBank
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
GenBank
GenBank
GenBank
View on Wikipedia
from Wikipedia
GenBank
Content
DescriptionNucleotide sequences for more than 300,000 organisms with supporting bibliographic and biological annotation.
Data types
captured
  • Nucleotide sequence
  • Protein sequence
OrganismsAll
Contact
Research centerNCBI
Primary citationPMID 21071399
Release date1982; 43 years ago (1982)
Access
Data format
WebsiteNCBI
Download URLncbi ftp
Web service URL
Tools
WebBLAST
StandaloneBLAST
Miscellaneous
LicenseUnclear[1]

The GenBank sequence database is an open access, annotated collection of all publicly available nucleotide sequences and their protein translations. It is produced and maintained by the National Center for Biotechnology Information (NCBI; a part of the National Institutes of Health in the United States) as part of the International Nucleotide Sequence Database Collaboration (INSDC).

In October 2024, GenBank contained 34 trillion base pairs from over 4.7 billion nucleotide sequences and more than 580,000 formally described species.[2][3]

The database started in 1982 by Walter Goad and Los Alamos National Laboratory. GenBank has become an important database for research in biological fields and has grown in recent years at an exponential rate by doubling roughly every 18 months.[4][5][3]

GenBank is built by direct submissions from individual laboratories, as well as from bulk submissions from large-scale sequencing centers.

Submissions

[edit]

Only original sequences can be submitted to GenBank. Direct submissions are made to GenBank using BankIt, which is a Web-based form, or the stand-alone submission program, table2asn. Upon receipt of a sequence submission, the GenBank staff examines the originality of the data and assigns an accession number to the sequence and performs quality assurance checks. The submissions are then released to the public database, where the entries are retrievable by Entrez or downloadable by FTP. Bulk submissions of Expressed Sequence Tag (EST), Sequence-tagged site (STS), Genome Survey Sequence (GSS), and High-Throughput Genome Sequence (HTGS) data are most often submitted by large-scale sequencing centers. The GenBank direct submissions group also processes complete microbial genome sequences.[6][7]

History

[edit]

Walter Goad of the Theoretical Biology and Biophysics Group at Los Alamos National Laboratory (LANL) and others established the Los Alamos Sequence Database in 1979, which culminated in 1982 with the creation of the public GenBank.[8] Funding was provided by the National Institutes of Health, the National Science Foundation, the Department of Energy, and the Department of Defense. LANL collaborated on GenBank with the firm Bolt, Beranek, and Newman, and by the end of 1983 more than 2,000 sequences were stored in it.

In the mid-1980s, the Intelligenetics bioinformatics company at Stanford University managed the GenBank project in collaboration with LANL.[9] As one of the earliest bioinformatics community projects on the Internet, the GenBank project started BIOSCI/Bionet news groups for promoting open access communications among bioscientists. During 1989 to 1992, the GenBank project transitioned to the newly created National Center for Biotechnology Information (NCBI).[10]

Genbank and EMBL: NucleotideSequences 1986/1987 Volumes I to VII.
CD-ROM of Genbank v100

Growth

[edit]
Growth in GenBank base pairs, 1982 to 2018, on a semi-log scale

The GenBank release notes for release 250.0 (June 2022) state that "from 1982 to the present, the number of bases in GenBank has doubled approximately every 18 months".[11][12] As of 15 June 2022, GenBank release 250.0 has over 239 million loci, 1,39 trillion nucleotide bases, from 239 million reported sequences.[11]

The GenBank database includes additional data sets that are constructed mechanically from the main sequence data collection, and therefore are excluded from this count.

Top 20 organisms in GenBank (Release 250)[11]
Organism base pairs
Triticum aestivum 2.15443744183×10^11
SARS-CoV-2 1.65771825746×10^11
Hordeum vulgare subsp. vulgare 1.01344340096×10^11
Mus musculus 3.0614386913×10^10
Homo sapiens 2.7834633853×10^10
Avena sativa 2.1127939362×10^10
Escherichia coli 1.5517830491×10^10
Klebsiella pneumoniae 1.1144687122×10^10
Danio rerio 1.0890148966×10^10
Bos taurus 1.0650671156×10^10
Triticum turgidum subsp. durum 9.981529154×10^9
Zea mays 7.412263902×10^9
Avena insularis 6.924307246×10^9
Secale cereale 6.749247504×10^9
Rattus norvegicus 6.548854408×10^9
Aegilops longissima 5.920483689×10^9
Canis lupus familiaris 5.776499164×10^9
Aegilops sharonensis 5.272476906×10^9
Sus scrofa 5.179074907×10^9
Rhinatrema bivittatum 5.178626132×10^9

Limitations

[edit]

An analysis of Genbank and other services for the molecular identification of clinical blood culture isolates using 16S rRNA sequences[13] showed that such analyses were more discriminative when GenBank was combined with other services such as EzTaxon-e[14] and the BIBI[15] databases.

GenBank may contain sequences wrongly assigned to a particular species, because the initial identification of the organism was wrong. A recent study showed that 75% of mitochondrial Cytochrome c oxidase subunit I sequences were wrongly assigned to the fish Nemipterus mesoprion resulting from continued usage of sequences of initially misidentified individuals.[16] The authors provide recommendations how to avoid further distribution of publicly available sequences with incorrect scientific names.

Numerous published manuscripts have identified erroneous sequences on GenBank.[17][18][19] These are not only incorrect species assignments (which can have different causes) but also include chimeras and accession records with sequencing errors. A recent manuscript on the quality of all Cytochrome b records of birds further showed that 45% of the identified erroneous records lack a voucher specimen that prevents a reassessment of the species identification.[20]

Another problem is that sequence records are often submitted as anonymous sequences without species names (e.g. as "Pelomedusa sp. A CK-2014" because the species are either unknown or withheld for publication purposes. However, even after the species have been identified or published, these sequence records are not updated and thus may cause ongoing confusion.[21]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

GenBank

View on Grokipedia
from Grokipedia
GenBank is the National Institutes of Health (NIH) genetic sequence database, an annotated collection of all publicly available nucleotide sequences, including DNA, RNA, and protein translations, designed to provide unrestricted access to the scientific community for research and analysis. Established in 1982 with its initial release containing 680,338 bases and 606 sequences, GenBank originated as a collaborative effort to centralize genetic data and has since grown exponentially under the management of the National Center for Biotechnology Information (NCBI). In 1992, NCBI assumed full responsibility for its development and maintenance, fostering international partnerships that accelerated its expansion from 51 million bases in 1990 to over 47 trillion base pairs across 5.9 billion sequences and more than 580,000 formally described species as of August 2025. As a core member of the International Nucleotide Sequence Database Collaboration (INSDC) alongside the DNA DataBank of Japan (DDBJ) and the European Nucleotide Archive (ENA), GenBank ensures daily data exchanges to maintain a synchronized, global repository of primary sequence information. This collaboration supports principles, allowing scientists from 121 countries to submit data via tools like the Submission Portal, which now includes features for uploading mRNA feature tables and accelerated processing for urgent cases such as sequences. Submissions undergo automated and manual quality checks, with options for delayed release until publication, while human sequences must exclude identifiable to protect privacy. GenBank's data powers downstream resources like and NCBI Gene, enabling applications in , , and , including a surge in viral submissions during the , with total viral sequences reaching 6.8 million by 2021, of which 2.2 million were coronaviruses (largely ). Bi-monthly releases are freely available via FTP, and users can access records through Nucleotide, BLAST searches, or NCBI Datasets, promoting FAIR (Findable, Accessible, Interoperable, Reusable) data principles.

Introduction and Overview

Definition and Purpose

GenBank is an open-access, annotated collection of all publicly available nucleotide sequences and their associated biological information, maintained by the National Center for Biotechnology Information (NCBI) at the U.S. National Institutes of Health (NIH). As the NIH's primary genetic sequence database, it serves as a comprehensive repository designed to provide unrestricted access to DNA and RNA sequence data for the global scientific community. Established in 1982 under NIH funding at Los Alamos National Laboratory, GenBank was created to centralize the rapidly expanding volume of DNA sequence data produced by early sequencing technologies, addressing the need for a centralized resource amid growing genomic research. Its core objectives include facilitating scientific discovery through free and open access to genetic information, thereby supporting advancements in genomics, evolutionary biology, and medicine. Specifically, it enables critical analyses such as sequence comparison, gene function prediction, and phylogenetic studies, which underpin research in molecular biology and related fields. GenBank records integrate nucleotide sequences with derived protein translations, allowing users to explore coding regions and their translated products without needing separate databases. As a member of the International Nucleotide Sequence Database Collaboration (INSDC), it synchronizes data daily with partner repositories ENA and DDBJ to ensure a unified global resource.

Scope and Content

GenBank encompasses a vast array of nucleotide sequence data, primarily consisting of DNA and RNA sequences submitted by researchers worldwide. These include genomic DNA from chromosomes and organelles, messenger RNA (mRNA) transcripts, ribosomal RNA (rRNA), transfer RNA (tRNA), and non-coding regions such as regulatory elements and introns. Each sequence entry is accompanied by rich annotations that describe biological features, including gene locations, protein products, exons, introns, coding sequences (CDS), and functional elements like promoters and polyadenylation sites. Additionally, entries link to bibliographic references, such as peer-reviewed publications, to provide context for the sequence's discovery and characterization. The database's coverage is exceptionally broad, encompassing sequences from over 581,000 formally named as well as unnamed organisms in metagenomic studies, spanning all domains of life: viruses, , , and eukaryotes ranging from unicellular protists to complex multicellular like , animals, and fungi. This includes both complete genome assemblies and partial sequences derived from targeted sequencing efforts, such as expressed sequence tags (ESTs) or amplicons from specific loci. Metagenomic samples from environmental sources, like soil microbiomes or ocean water, further extend the scope to uncultured microbial communities, enabling research into and dynamics. By late 2024, GenBank held sequences representing more than 4.7 billion records, with the total accumulating to approximately 34 trillion base pairs, a figure that continued to grow rapidly into . Content in GenBank is systematically organized into divisions to facilitate targeted access and management. Standard divisions categorize sequences by type or source, such as PRI for sequences (including ), ROD for , PLN for and fungi, BCT for , VRL for viruses, and ENV for environmental samples. Specialized divisions handle high-throughput data, including WGS for whole shotgun assemblies, TSA for transcriptome shotgun assemblies, and GSS for genome survey sequences. This structure supports efficient storage and retrieval, with each division subdivided into numbered files (e.g., gbpri1.seq for the first part of sequences) to manage the enormous volume of data. As of Release 268.0 in August 2025, the database exceeded 47 trillion base pairs across traditional and set-based records. A distinctive feature of GenBank is its emphasis on annotation depth and standardization, which enhances the interpretability of sequences for scientific use. Annotations employ controlled vocabularies defined by the International Nucleotide Sequence Database Collaboration (INSDC), ensuring consistent terminology for features—such as "/gene" for gene names, "/product" for protein descriptions, and "/inference" for evidence supporting predictions like similarity to known sequences or experimental validation. This richness distinguishes GenBank from raw sequence repositories, providing users with curated insights into sequence function, evolution, and variation without requiring extensive post-processing. Bibliographic links further integrate sequences with the primary literature, fostering and advancing genomic research across disciplines.

History and Development

Origins and Early Years

GenBank was initiated in 1982 by Walter Goad at the (LANL), with funding from the U.S. Department of Energy (DOE) as well as contributions from the (NIH) and other agencies, to address the increasing influx of DNA sequences produced through manual sequencing methods that were becoming more prevalent in research. Goad, a biophysicist in LANL's Theoretical Biology and Biophysics Group, envisioned a centralized repository to collect, annotate, and distribute nucleic acid sequence data, filling a critical need as the volume of published sequences grew beyond what individual researchers could manage. Early operations centered on quarterly releases of the database, distributed primarily via magnetic tapes to academic and research institutions worldwide, allowing researchers to access the data on their local systems. The inaugural public release, known as Release 3, occurred in December 1982 and included 606 sequences comprising 680,338 base pairs, reflecting the modest scale of sequence data available at the time. Key members of the LANL team, including Christian Burks, played pivotal roles in curating entries, developing submission protocols, and ensuring amid the nascent field's demands. The team encountered substantial challenges from the of submissions, which rapidly outstripped the resources and storage capabilities of hardware, prompting ongoing optimizations in compression and retrieval efficiency. To facilitate broad accessibility and portability across diverse environments, GenBank adopted a text-based flat-file format from the outset, featuring structured records with , annotations, and references, supplemented by basic indexing for keyword-based searches. This design emphasized simplicity and interoperability, enabling easy transfer via tapes without reliance on .

Key Milestones and Transitions

In 1988, the U.S. established the (NCBI) within the at the (NIH) to advance computational biosciences, including the management of genetic sequence data. This marked the beginning of GenBank's transition from its initial custodians at to federal oversight under NIH. The handover process spanned from 1989 to 1992, culminating in October 1992 when NCBI assumed full responsibility for GenBank's operations, data distribution, and development. Concurrently, NCBI introduced the retrieval system in 1991, enabling integrated online access to GenBank sequences alongside related protein, taxonomy, and literature data, which revolutionized user interaction with the database. The 1990s brought pivotal technological integrations that expanded GenBank's utility and reach. In 1990, NCBI developed the Basic Local Alignment Search Tool (BLAST), a high-speed for identifying sequence similarities against GenBank entries, facilitating rapid genomic comparisons essential for emerging research. Throughout the decade, GenBank adopted internet-based distribution methods, including anonymous FTP access and web interfaces, shifting from primary reliance on CD-ROMs to network delivery, which accelerated as submissions grew exponentially. GenBank's release numbering system, initiated with Release 3 in December 1982, continued bimonthly, providing structured versioning of the to track updates systematically. The 2000s and 2010s saw GenBank adapt to the explosion of high-throughput sequencing data, driven by advances in genomic technologies. By December 2000 (Release 121), GenBank had amassed over 10 million sequences, encompassing 11 billion bases, reflecting the impact of large-scale projects like the Human Genome Project. To accommodate unfinished high-throughput genomic sequences, NCBI created the High-Throughput Genomic Sequences (HTGS) division in 1999, allowing rapid deposition of draft data without full assembly. By 2010, GenBank began incorporating next-generation sequencing (NGS) outputs through the Whole Genome Shotgun (WGS) division and coordination with the Sequence Read Archive (SRA), handling the surge in short-read data from platforms like Illumina, which multiplied sequence volumes by orders of magnitude. From 2020 to 2025, GenBank underwent transitions to manage escalating data volumes and specialized applications, including enhanced cloud-based infrastructure for associated . The drove a surge in viral sequence submissions, with genomes increasing significantly and contributing to overall database growth. NCBI made SRA data, which includes raw reads linked to GenBank entries, available via cloud platforms like AWS and , enabling scalable access to petabyte-scale datasets without local downloads. For , submission guidelines were refined as of March 2025 to streamline handling of environmental and sequences, encouraging raw read submissions and detailed metadata to support assembly and annotation of uncultured microbial communities through targeted wizards and validation tools.

Organization and Collaboration

International Nucleotide Sequence Database Collaboration (INSDC)

The International Sequence Database Collaboration (INSDC) was established in 1987 as a formal agreement among GenBank, the (EMBL) Sequence Database (now the European Nucleotide Archive or ENA at EMBL-EBI), and the DNA Data Bank of (DDBJ) to coordinate the collection, , and dissemination of data worldwide. This arose from earlier efforts in 1986 between GenBank and EMBL to standardize data formats, with DDBJ joining to create a unified framework that prevents data redundancy and ensures comprehensive global coverage of publicly available sequences. The primary purpose is to facilitate synchronized exchange of core data, enabling researchers to submit sequences to any partner database while guaranteeing identical access across all three archives. Submitters may choose any partner database, though it is recommended to use the one closest geographically or most convenient for support: , managed by the (NCBI) in the United States; ENA at EMBL-EBI in ; and DDBJ, operated by the National Institute of Genetics in . To maintain consistency, the partners engage in daily data mirroring, exchanging new and updated records in standardized formats such as the Feature Table, which ensures that the core datasets—comprising annotated sequences—are identical across all databases without duplication. This synchronization process supports redundancy for data preservation and allows seamless querying from any INSDC portal. While the core data are mirrored identically, each partner adds unique value through region-specific enhancements. For instance, GenBank incorporates U.S.-focused biological annotations linked to resources like and includes dedicated records for patent sequences derived from intellectual property filings, which are not duplicated in ENA or DDBJ but remain accessible globally via the shared framework. The total holdings of the INSDC, synchronized across partners, comprise over 5.7 billion sequences as of mid-2025, underscoring the collaboration's role in scaling genomic . In the 2020s, the INSDC has evolved to address emerging data types and accessibility needs, including joint development of standards for metagenomic and environmental sequencing data in partnership with the Genomics Standards Consortium to improve metadata consistency for and studies. Additionally, the has reinforced policies aligned with (Findable, Accessible, Interoperable, Reusable) principles, mandating unrestricted public access to all deposited sequences via unique accession numbers and prohibiting proprietary restrictions on core data. In 2023, the founding members signed a Founders to formalize their , and the INSDC has since developed a Membership to attract additional qualified sequence archives as new members, enhancing global representation. These updates ensure the INSDC remains adaptable to high-throughput sequencing advancements while upholding its foundational commitment to equitable global data sharing.

Data Management and Standards

GenBank employs a multi-tiered curation process to maintain the integrity and utility of its sequence data, involving both professional by NCBI staff for high-profile or complex entries, such as those from or genomes, and community-driven updates through author revisions. NCBI staff conduct manual reviews and annotations for select sequences, ensuring accuracy in biological interpretation, while submitters can request updates or corrections post-release, which are verified and incorporated by NCBI curators. All annotations in GenBank records utilize the Feature Table format, a structured system for describing sequence features like genes, exons, and regulatory elements, which facilitates consistent representation across entries. Adherence to established standards is central to GenBank's data management, with the database following the International Nucleotide Sequence Database Collaboration (INSDC) Feature Table Definition (FTD) document to define feature keys, locations, and qualifiers for annotations. This ensures interoperability and precision in describing biological entities, supplemented by controlled vocabularies such as those from the Sequence Ontology for terms related to genomic features. Validation checks are rigorously applied during processing, encompassing automated and manual assessments of sequence integrity, such as verifying base composition and length, alongside compliance to prevent errors in organism naming or feature labeling. Internal management tools at NCBI support ongoing through pipelines designed for error detection and mitigation, including contamination screening via the Foreign Contaminant Screen (FCS) tool to identify non-target sequences in submissions. GenBank data are released bimonthly in versioned flat files, allowing users to track changes and access complete datasets via FTP, with daily incremental updates for timely synchronization across INSDC partners. These releases incorporate to preserve historical records while enabling corrections. Unique to GenBank's policies is the status of all deposited data, permitting unrestricted use, reuse, and distribution without licensing fees, though submitters retain any applicable rights. For pre-publication sequences, NCBI handles confidential submissions by withholding them from public access until the specified release date or publication, at which point they enter the open archive.

Submission and Annotation

Submission Processes

Researchers contribute new nucleotide sequences to GenBank through several established pathways designed to accommodate varying submission sizes and complexities. For small-scale submissions, such as individual sequences or sets up to 500 entries or 50 kb total, the web-based BankIt tool allows users to enter data interactively via a browser interface, guiding the preparation of sequence and feature information. Larger or bulk submissions, including annotated genomes, utilize the standalone tbl2asn software, which converts tabular data and files into the required format (.sqn) for submission. Sequencing centers and high-volume submitters often employ direct FTP uploads to NCBI servers or email submissions to [email protected], facilitating efficient transfer of extensive datasets. All submissions require specific formats and mandatory metadata to ensure compatibility and traceability. Sequence data must be provided in , with annotations in (.sqn) for structured features. Essential metadata includes the source organism (with details), submitter and information, references (if applicable), and collection details such as isolate, strain, or geographic location. These elements are verified during submission to align with International Sequence Database Collaboration (INSDC) standards. The submission workflow begins with pre-submission validation using built-in tools like the validator in tbl2asn or the Submission Portal's automated checks, which detect issues such as errors, , or chimeric sequences. Once submitted, NCBI staff perform biological review, assigning provisional accession numbers typically within two working days; examples include standard accessions like U12345 (one letter followed by five digits) or Whole Genome (WGS) accessions such as AABM01000000. Full processing, including integration into public releases, takes days to weeks depending on complexity, after which data undergo post-submission . GenBank handles substantial submission volumes, with over 7 million new sequence records added in 2023 alone, reflecting an annual influx exceeding 1 million sequences from global researchers. To manage this scale, specialized tracks exist for high-priority data types, such as complete genomes submitted via the Genome Submission Portal and metagenomic assemblies through the Transcriptome Shotgun Assembly (TSA) pathway, ensuring streamlined processing for large-scale genomic projects.

Annotation Guidelines and Quality Control

GenBank annotations are structured using a feature table format that employs qualifier-value pairs to describe biological elements within sequences. These pairs follow the syntax /qualifier="value", where qualifiers provide specific attributes such as names or product descriptions. For instance, the qualifier /gene="ABC1" identifies a symbol, while /product="protein X" specifies the encoded protein. This system allows for precise, machine-readable descriptions of features like coding sequences (CDS), , and sources. Mandatory fields ensure basic metadata integrity, with the source organism qualifier /organism required on every source feature to denote the biological origin, accompanied by /mol_type (e.g., /mol_type="genomic DNA") to classify the sequence type. Optional qualifiers enhance detail, such as /locus_tag for unique gene identifiers within a record or /note for additional context. Submitters are responsible for providing accurate annotations, with NCBI offering templates and validation tools like table2asn to facilitate compliance during submission. Evidence tags distinguish between experimental and computational support for annotations. The /experiment qualifier documents direct evidence, such as /experiment="northern blot", while /inference captures computational predictions, formatted as /inference="ab initio prediction:Prodigal:2.6". These tags promote transparency and reproducibility, adhering to controlled vocabularies to maintain consistency across submissions. Quality control begins with automated validation during submission processing, using tools to check sequence validity (e.g., detecting internal stop codons or invalid characters), nomenclature consistency (e.g., standardized organism names from the NCBI Taxonomy database), and potential contamination (e.g., mismatched primer sequences or unexpected organism assignments). Common errors, such as missing source descriptors or improper geographic location codes, generate discrepancy reports for correction. Incomplete or erroneous submissions may be rejected or require revisions before acceptance. For complex annotations, NCBI staff conduct manual reviews to verify intricate features, ensuring alignment with INSDC standards. This hybrid approach minimizes errors while handling the volume of submissions, with tools like the GenBank Submission Portal providing real-time feedback. Submitters retain ownership of annotations but must address validation issues to proceed. In the 2020s, enhancements have streamlined for high-throughput data, including support for GFF3 format uploads to accommodate next-generation sequencing (NGS) assemblies and structured evidence reporting. Standards for synthetic sequences specify the SYN division and qualifiers like /organism="synthetic construct" or /note to flag engineered elements, with validation ensuring clear distinction from natural sequences. As of 2025, the Submission Portal supports uploading feature tables for eukaryotic nuclear mRNA sequences, including coding sequences (CDS) and protein annotations; the Popset database retired in January 2025, with submitters directed to use BioProject records; support for experimental and inferential Third Party (TPA) sequences ended in January 2025; and AGP files for genome assemblies are no longer accepted, with submitters instructed to use 'N's in sequences for gaps. These updates, including accelerated processing for specific datasets like , reflect ongoing efforts to adapt to evolving genomic technologies.

Access and Retrieval

User Interfaces and Tools

GenBank data is primarily accessed through the (NCBI) platforms, offering a suite of integrated tools for searching, viewing, and analyzing sequences. The core interface for text-based retrieval is the database, which allows users to query GenBank records using accession numbers, keywords, author names, or filters. For example, entering an accession like "U49845" retrieves the full annotated sequence record, while a keyword search such as "human BRCA1 gene" yields relevant entries with links to related genomic and literature data. Graphical browsing is facilitated by the Genome Data Viewer (GDV), a web-based tool that displays GenBank sequences in a visual format, enabling users to navigate assemblies, zoom into regions, and overlay annotations like genes and variants. GDV supports exploration of eukaryotic genomes from organisms such as humans, mice, and , with features for comparative viewing across species. This interface is particularly useful for contextual analysis of sequence data without needing to download files. For sequence similarity searches, the Basic Local Alignment Search Tool (BLAST) integrates directly with GenBank, allowing users to input a query sequence and compare it against the nucleotide database to identify homologous regions. Options like blastn for nucleotide-to-nucleotide alignments compute , aiding in functional inference and phylogenetic studies. BLAST results link back to original GenBank records for detailed annotation review. Supporting tools enhance data handling and organization. The Sequence View provides an annotated display of individual records, highlighting features such as coding regions, promoters, and references in a graphical panel embedded within results. The Taxonomy Browser enables filtering and navigation of GenBank sequences by organismal hierarchy, from broad domains like to specific strains, streamlining organism-specific queries. For bulk operations, Batch Entrez permits uploading lists of identifiers (up to thousands) to retrieve multiple records simultaneously, ideal for exporting subsets like all sequences from a particular study for local analysis. Programmatic access is available via the Programming Utilities (E-utilities) API, which supports scripted searches and retrievals in languages like Python or , including functions for fetching data by ID or term. NCBI Datasets offers an additional and for genome-centric queries, with redesigned views for easier navigation. While no dedicated mobile apps exist for GenBank, the web interfaces are responsive, allowing basic searches and views on mobile devices through browsers. All these interfaces are freely accessible without login requirements for basic use, promoting open scientific collaboration, and integrate seamlessly with for linking to associated publications. This no-cost model ensures broad availability to researchers worldwide.

Data Formats and Downloads

GenBank primarily distributes its data in the flat-file format, known as the GenBank Flat File (GBFF), which structures each record with a header section, a features table for annotations, and the or protein itself. The header includes fields such as LOCUS (specifying the name, , type, and division), DEFINITION (a brief description), ACCESSION (a ), VERSION (including the GI number for versioning), SOURCE (organism details), and (citation information). The features table delineates annotated elements like coding (CDS), genes, and regulatory regions using a standardized vocabulary, with locations and qualifiers providing precise details such as product names or translations. This format, exemplified in sample records like accession U49845 for the Saccharomyces cerevisiae TCP1-beta gene, ensures human-readable and parseable representation of complex biological data. Alternative formats cater to specific use cases: provides a simplified, sequence-only output with a definition line starting with ">" followed by the accession and description, ideal for alignment tools and lacking annotations. (Abstract Syntax Notation One) offers a structured, binary-compatible representation for programmatic access and exchange, supporting hierarchical data like sequences and metadata in a machine-optimized way. These formats, alongside GBFF, are available for download to accommodate diverse computational needs. Data downloads occur via the NCBI FTP site at ftp://ftp.ncbi.nih.gov/genbank/, where full bimonthly releases—such as Release 268.0 from August 2025, encompassing over 47 trillion bases and 5.9 billion records—are provided in GBFF, , and . Incremental updates, reflecting daily additions from submissions, are also accessible to minimize bandwidth usage for users tracking recent changes. For targeted subsets, NCBI Datasets enables cloud-based access and downloads of genomic data across domains, supporting formats like for sequences, GFF3 for annotations, and for metadata, integrated with GenBank records. As part of the International Nucleotide Sequence Database Collaboration (INSDC) with EMBL-EBI (ENA) and DDBJ, GenBank synchronizes data using the shared Feature Table format, which employs EMBL-like flat-file structures for consistent annotation exchange, including feature keys (e.g., CDS), locations, and qualifiers (e.g., /product). XML variants of this table provide machine-readable annotations, facilitating automated parsing and across the databases. Best practices for handling GenBank data emphasize managing file sizes—full releases often exceed 5 TB uncompressed—through compression available on the FTP site, and employing via stable accession numbers or identifiers to track updates without re-downloading entire datasets. Users are advised to verify formats against official documentation to ensure compatibility with analysis pipelines.

Growth and Impact

GenBank's data volume has exhibited remarkable growth since its inception, doubling approximately every 18 months from 1982 onward, a pattern sustained through advancements in sequencing technologies and increased research output. This exponential trajectory reflects the broader evolution of genomics, where falling sequencing costs have democratized data generation. In the 1980s, Sanger sequencing costs were around $5–10 per base pair, limiting submissions to targeted experiments and resulting in modest accumulation. By the 2020s, costs had plummeted to less than $0.01 per base pair, enabling high-throughput projects and fueling sustained expansion. Early growth from the to was relatively linear, transitioning from hundreds of thousands of bases to tens of millions as manual and early automated sequencing methods prevailed. Release 1 in 1983 contained just 0.68 million bases from 680 sequences, primarily from small-scale studies of genes and viruses. By 1990, the database had reached 51 million bases across over 41,000 sequences, driven by accumulating data from labs worldwide. The 2000s marked a shift to with the advent of next-generation sequencing (NGS) technologies around , which drastically increased throughput and reduced per-base costs. The completion of the in 2003, sequencing approximately 3 billion base pairs, exemplified this surge and encouraged global submissions, propelling GenBank past 100 billion bases by 2010. The following table summarizes key milestones in GenBank releases, highlighting the scale of growth:
Release YearRelease NumberTotal Bases (approximate)Key Driver
198310.68 millionInitial manual sequencing efforts
1990~5051 millionEarly and targeted genomics
200011411 billionPre-NGS high-volume projects
2010178108 billionNGS adoption
20222501.39 trillion and large-scale surveys
In the 2020s, growth has accelerated further due to and environmental sequencing initiatives, which generate vast datasets from microbial communities and ecosystems, outpacing even NGS-driven increases of the prior decade. These trends underscore GenBank's role as a foundational repository, with ongoing expansions anticipated from emerging fields like .

Current Statistics and Significance

As of August 2025, GenBank release 268.0 contains 47.01 trillion base pairs across 5.90 billion sequences, spanning more than 581,000 formally described . The database receives approximately 1.8 million new sequences daily through incremental updates, reflecting its rapid expansion driven by high-throughput sequencing technologies. The content breakdown highlights the dominance of bacterial and archaeal sequences, which constitute the majority of records due to their prevalence in microbial research. Eukaryotic genomes are comprehensively represented, including full coverage of the with over 28 million entries for Homo sapiens. Viral sequences have experienced particularly rapid growth following the , with more than 9 million entries for alone. GenBank plays a pivotal role in modern science by facilitating global research collaborations through the International Nucleotide Sequence Database Collaboration (INSDC), enabling standardized access to data worldwide. It supports AI-driven predictions, such as those from , which relies on GenBank-derived sequences via for training models and advancing fields like . The database's economic impact is substantial in and pharmaceuticals, where it underpins genomics-based innovations, including and development. Millions of scientific papers reference GenBank accessions annually, underscoring its foundational influence across . In 2025, GenBank has seen enhanced holdings in metagenomic data, bolstered by contributions from initiatives like the Earth BioGenome Project, which deposits reference genomes to catalog eukaryotic biodiversity and support conservation efforts.

Challenges and Limitations

Data Quality and Errors

GenBank, as a comprehensive repository of sequences, faces ongoing challenges with stemming from the diverse origins of submissions and the volume of legacy records. Common errors include species misidentifications, where sequences are incorrectly assigned to taxa due to taxonomic ambiguities or submitter oversights. For instance, analyses of (Cytb) gene sequences for fishes identified approximately 2% (1,303 out of 65,326 records) as potentially problematic, involving species misidentification, laboratory contamination, or PCR chimeras. Contamination from laboratory artifacts, such as reagent-derived sequences or cross-sample mixing, is another prevalent issue, with large-scale screens identifying over 2,000,000 contaminated entries across the database. Additionally, outdated annotations persist, where functional or taxonomic labels fail to incorporate subsequent research findings, leading to discrepancies between GenBank records and current biological knowledge. These errors often trace back to early manual submissions, which lacked rigorous validation, and more recent next-generation sequencing (NGS) assembly processes, where algorithmic limitations can introduce chimeric or erroneous contigs. In the case of , early submissions prior to 2020 included mislabeled variants and sequences with anomalies that propagated uncertainties in viral phylogenetics. NGS-specific issues, such as errors in long-read assemblies, further compound inaccuracies when unfiltered drafts are deposited. Such problems have been exacerbated by the rapid influx of data during events like the , where incomplete metadata accompanied high-volume uploads. Quantitatively, taxonomic misidentifications in metazoan sequences are estimated at less than 1% at the level, though higher rates—up to 32% sequence discrepancies—appear in re-sequenced specimens for specific groups like tetrapods. These inaccuracies distort phylogenetic reconstructions, assessments, and evolutionary analyses by introducing noise that biases tree topologies or inflates divergence estimates. Detection of errors relies on community-driven flagging through update submissions and NCBI's discrepancy reports, which evaluate annotations for inconsistencies like mismatched taxonomy or sequence anomalies. Tools such as the Foreign Contamination Screen (FCS) aid in identifying contaminants in new assemblies, but legacy data remains intact without automatic purging to preserve historical records. This manual and semi-automated approach, while effective for ongoing curation, underscores the database's vulnerability to propagated errors from unchecked early entries.

Future Directions and Improvements

GenBank and its collaborators in the International Nucleotide Sequence Database Collaboration (INSDC) are pursuing several upcoming initiatives to enhance automated and error correction processes. Recent advancements include the integration of and techniques for improving viral protein in metagenomic datasets, particularly for uncultivated genomes, by leveraging protein models to detect remote homology and reduce errors. These efforts build on existing automated tools, such as the FLu ANnotation (FLAN) system used by NCBI for validating and predicting protein sequences in submissions, which accelerates processing and ensures consistency in high-volume data streams. Future developments emphasize -specific models trained on large datasets like those in GenBank to incorporate genomic context and further minimize functional inaccuracies. INSDC members are advancing standardized reporting for metagenomic data through the adoption of the Genomic Standards Consortium's Minimum Information about any (x) Sequence (MIxS) framework, which extends core metadata requirements to include environmental and sample-specific details for genome and metagenome sequences. This standardization facilitates better comparability across studies and supports the submission of sequences and metagenome-assembled genomes with structured ontologies. Regarding versioning, INSDC protocols maintain trails via unique accession numbers and update mechanisms, allowing submitters to revise records while preserving historical , though challenges in propagating corrections across linked entries persist due to limited systematic tracking. To address ongoing limitations, there is growing emphasis on improving data provenance through enhanced metadata in BioSample records, which promote consistency in taxonomic assignments and of sequence origins. Erroneous records are handled via submitter-initiated updates or flagging, as GenBank ownership remains with depositors, preventing direct NCBI modifications but enabling through replacement with corrected versions. For in the face of exabyte-scale growth, NCBI is leveraging cloud platforms, such as hosting BLAST databases on and , to distribute computational loads and support federated access to large datasets without centralizing all storage. In a broader vision, GenBank aligns with principles—Findable, Accessible, Interoperable, and Reusable—through resources like BioProject and BioSample, which enhance metadata interoperability and global . Potential expansions include greater integration with related NCBI archives, such as the Epigenomics DataBase, to incorporate epigenomic datasets alongside nucleotide sequences, fostering comprehensive genomic analyses while maintaining open-access standards.

References

  1. https://www.ncbi.nlm.nih.gov/genbank/
  2. https://www.ncbi.nlm.nih.gov/genbank/statistics
  3. https://www.ncbi.nlm.nih.gov/books/NBK148949/
  4. https://ncbiinsights.ncbi.nlm.nih.gov/2025/08/26/genbank-release-268-0/
  5. https://www.ncbi.nlm.nih.gov/genbank/about/
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC11701615/
  7. https://www.genome.gov/25520321/online-education-kit-1982-genbank-database-formed
  8. https://www.ncbi.nlm.nih.gov/genbank/samplerecord/
  9. https://www.ncbi.nlm.nih.gov/genbank/release/current
  10. https://ncbiinsights.ncbi.nlm.nih.gov/2025/01/13/ncbi-resources-2025-nucleic-acids-research-database-issue/
  11. https://www.ajmc.com/view/how-genbank-databases-speed-vaccine-drug-developmentand-precision-medicine
  12. https://circulatingnow.nlm.nih.gov/2016/03/03/genbank-the-early-years-of-big-data/
  13. https://www.lanl.gov/media/publications/1663/0818-making-sense-of-sequences
  14. https://www.genomeweb.com/archive/quarter-century-genbank
  15. https://www.ncbi.nlm.nih.gov/Web/Newsltr/Summer99/decade.html
  16. https://www.ncbi.nlm.nih.gov/genbank/release/113/
  17. https://www.ncbi.nlm.nih.gov/genbank/htgs
  18. https://www.ncbi.nlm.nih.gov/sra
  19. https://ncbiinsights.ncbi.nlm.nih.gov/2024/10/16/changes-sra-data-access-aws-gcp/
  20. https://www.ncbi.nlm.nih.gov/genbank/metagenome/
  21. https://academic.oup.com/nar/article/53/D1/D56/7903376
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC5753279/
  23. https://fairsharing.org/organisations/1504
  24. https://www.insdc.org/about-insdc/
  25. https://www.ncbi.nlm.nih.gov/genbank/submit
  26. https://www.ncbi.nlm.nih.gov/education/patent_and_ip_faqs/
  27. https://datascience.codata.org/articles/dsj-2021-028
  28. https://academic.oup.com/nar/article/53/D1/D62/7899524
  29. https://www.insdc.org/news/insdc-publishes-guidance-for-prospective-new-members-20-05-2024/
  30. https://www.ncbi.nlm.nih.gov/sra/docs/sequence-data-processing/
  31. https://www.insdc.org/submitting-standards/feature-table/
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC1175956/
  33. https://ftp.ncbi.nlm.nih.gov/genbank/
  34. https://www.ncbi.nlm.nih.gov/genbank/table2asn
  35. https://submit.ncbi.nlm.nih.gov/about/genbank/
  36. https://www.ncbi.nlm.nih.gov/genbank/submit_types
  37. https://www.ncbi.nlm.nih.gov/genbank/wgs.submit
  38. https://www.ncbi.nlm.nih.gov/genbank/genomesubmit_annotation
  39. https://www.ncbi.nlm.nih.gov/genbank/evidence
  40. https://www.ncbi.nlm.nih.gov/genbank/validation/
  41. https://www.ncbi.nlm.nih.gov/genbank/genome_validation
  42. https://www.ncbi.nlm.nih.gov/nucleotide/
  43. https://blast.ncbi.nlm.nih.gov/Blast.cgi
  44. https://www.ncbi.nlm.nih.gov/projects/sviewer/
  45. https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi
  46. https://www.ncbi.nlm.nih.gov/sites/batchentrez
  47. https://www.ncbi.nlm.nih.gov/home/develop/api/
  48. https://www.ncbi.nlm.nih.gov/datasets/docs/v2/api/rest-api/
  49. https://academic.oup.com/nar/article/52/D1/D134/7331009
  50. https://www.ncbi.nlm.nih.gov/genbank/fastaformat
  51. https://www.ncbi.nlm.nih.gov/datasets/docs/v2/troubleshooting/faq/
  52. https://www.ncbi.nlm.nih.gov/genbank/collab
  53. https://www.ncbi.nlm.nih.gov/genbank/ftp/
  54. https://www.ncbi.nlm.nih.gov/genbank/sequenceids/
  55. https://arep.med.harvard.edu/pdf/Shendure_Waterston_2017.pdf
  56. https://www.genome.gov/about-genomics/fact-sheets/DNA-Sequencing-Costs-Data
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC4727787/
  58. https://academic.oup.com/nar/article/47/D1/D94/5144964
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC3878092/
  60. https://www.nature.com/articles/s41586-021-03819-2
  61. https://pubmed.ncbi.nlm.nih.gov/39558184/
  62. https://www.earthbiogenome.org/
  63. https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2018.00030/full
  64. https://genomebiology.biomedcentral.com/articles/10.1186/s13059-020-02023-1
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC7802636/
  66. https://www.mdpi.com/2076-2607/12/11/2187
  67. https://www.nature.com/articles/s41467-023-42336-w
  68. https://www.pnas.org/doi/10.1073/pnas.1911714116
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC12186718/
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC4216915/
  71. https://genomebiology.biomedcentral.com/articles/10.1186/s13059-024-03198-7
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC9677457/
  73. https://journals.asm.org/doi/10.1128/mbio.03206-23
  74. https://link.springer.com/protocol/10.1007/978-1-0716-3838-5_20
  75. https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2024.1278228/full
  76. https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-023-05245-9
  77. https://pmc.ncbi.nlm.nih.gov/articles/PMC3013719/
Add your contribution
Related Hubs
Contribute something
User Avatar
No comments yet.